Bone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell TransplantationBone MarrowBone Marrow CellsTransplantation ConditioningStem Cell TransplantationGraft vs Host DiseaseLiver TransplantationWhole-Body IrradiationMultiple MyelomaCombined Modality TherapyBone Marrow PurgingGraft SurvivalMelphalanHematopoietic Stem CellsTreatment OutcomeCyclophosphamideKidney TransplantationBusulfanRemission InductionRecurrenceLymphoma, Non-HodgkinBone and BonesPeripheral Blood Stem Cell TransplantationTransplantation ChimeraLeukemiaAntineoplastic Combined Chemotherapy ProtocolsTissue DonorsAnemia, AplasticHematopoietic Stem Cell MobilizationCarmustineSalvage TherapyStem CellsEtoposideHistocompatibility TestingHematologic NeoplasmsDisease-Free SurvivalTransplantation, IsogeneicSurvival AnalysisHeart TransplantationHodgkin DiseaseTime FactorsHematopoiesisAntigens, CD34CytarabineRetrospective StudiesHistocompatibilityImmunosuppressive AgentsGranulocyte Colony-Stimulating FactorSurvival RateLung TransplantationGraft RejectionLeukemia, Myeloid, AcuteCell TransplantationTransplantation ImmunologyFollow-Up StudiesBone Marrow DiseasesMice, Inbred C57BLOrgan TransplantationVincristineMyelodysplastic SyndromesImmunosuppressionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveColony-Forming Units AssayLeukapheresisRadiation ChimeraLymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisLeukemia, MyeloidMyeloablative AgonistsT-LymphocytesBlood Transfusion, AutologousGraft vs Tumor EffectAcute DiseaseHepatic Veno-Occlusive DiseaseCells, CulturedBone Marrow ExaminationCell DifferentiationLymphocyte DepletionHLA AntigensGraft vs Host ReactionThiotepaPancreas TransplantationIslets of Langerhans TransplantationNeoplasm, ResidualFlow CytometryBone RemodelingLeukocyte TransfusionCell SeparationBone Marrow NeoplasmsCyclosporinePrednisoneTransplantationChimeraSevere Combined ImmunodeficiencyAntibodies, MonoclonalCord Blood Stem Cell Transplantation